Found: 4
Select item for more details and to access through your institution.
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2013, v. 22, n. 6, p. 571, doi. 10.1002/pds.3405
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 4, p. 720, doi. 10.1093/cid/ciac130
- By:
- Publication type:
- Article
341. Risk of Type 2 Diabetes Mellitus after Antiretroviral Therapy Initiation in Individuals Living with HIV in the United States.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S181, doi. 10.1093/ofid/ofz360.414
- By:
- Publication type:
- Article
Switching to DTG/3TC Is non-inferior to continuing current antiretroviral regimen at week 48: SALSA subgroup analyses.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S298
- By:
- Publication type:
- Article